414910-21-7

Basic information

• Product Name: 2-(4-fluorophenyl)piperidin-4-one
• Synonyms: 2-(4-fluorophenyl)piperidin-4-one;4-Piperidinone, 2-(4-fluorophenyl)-
• CAS NO: 414910-21-7
• Molecular Formula: C₁₁H₁₂FNO
• Molecular Weight: 193.22
• Mol File: 414910-21-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(4-fluorophenyl)piperidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-fluorophenyl)piperidin-4-one(414910-21-7)
• EPA Substance Registry System: 2-(4-fluorophenyl)piperidin-4-one(414910-21-7)

Safety Data

• Hazardous Substances Data: 414910-21-7(Hazardous Substances Data)

Upstream product

• 620-08-6 4-methoxypyridine 
• 414910-19-3 benzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate 
• 352-13-6 4-flourophenylmagnesium bromide 
• 414910-20-6 benzyl 2-(4-fluorophenyl)-4-oxopiperidine-1-carboxylate 

Downstream Products

• 414910-25-1 2-(S)-(4-fluoro-phenyl)-4-oxo-piperidine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)ethyl]-methylamide 

Relevant articles and documents

BENZOXAZEPINES AS INHIBITORS OF P13K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE

The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds. 9936396.1

BENZOXAZEPINES AS INHIBITORS OF MTOR AND METHODS OF THEIR USE AND MANUFACTURE

The invention is directed to inhibitors of mTOR and pharmaceutically acceptable salts or solvates thereof, as well as methods of using them. The inhibitors are generally of structural formula wherein the combination of R1 and R2 are

BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE

The invention is directed to Compounds of Formula (I): the invention provides compounds that inhibit, regulate, and/or modulate P13K and/or mTOR that are useful in the treatment of hyperproliferative diseases, such as cancer, in mammals. This invention al

Chemical compounds

Formula (1) wherein R represents a halogen atom or a C1-4 alkyl group; R1 represents a C1-4 alkyl group; R2 represents hydrogen or a C1-4 alkyl group; R3 represents hydrogen, or a C1-4 alkyl group; R4 represents a trifluorometyl group; R5 represents hydrogen, a C1-4 alkyl group or C(0)R6; R6? represents C1-4 alkyl, C3-7 cycloalkyl, NH(C1-4 alkyl) or N(C1-4alkyl)2; m is zero or an integer from 1 to 3; n is an integer from 1 to 3 and pharmaceutically acceptable salts and solvates thereof; to processes for their preparation and their use in the treatment of conditions mediated bytachykinins.